Siemens Healthineers AG

SHL1

Company Profile

  • Business description

    Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.

  • Contact

    Siemensstrasse 3
    ForchheimBY91301
    DEU

    T: +49 9131843385

    https://www.siemens-healthineers.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 September 2026

    Employees

    74,000

Stocks News & Analysis

stocks

Earnings margins to improve for mining specialist

Premium products drive margins yet shares fully valued.
stocks

3 ASX opportunities after earnings season

Uncovering key opportunities following results.
stocks

Nvidia: Hugging Face acquisition both a wise offensive and defensive move

We think this improves Nvidia’s position within the open-source community.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,202.6010.10-0.11%
CAC 408,278.777.63-0.09%
DAX 4026,046.4043.080.17%
Dow JONES (US)53,414.25271.86-0.51%
FTSE 10010,831.090.43-0.00%
HKSE25,414.95235.92-0.92%
NASDAQ26,506.9977.07-0.29%
Nikkei 22566,460.111,439.172.21%
NZX 50 Index13,921.4252.76-0.38%
S&P 5007,718.6029.11-0.38%
S&P/ASX 2009,010.8012.60-0.14%
SSE Composite Index3,930.950.830.02%

Market Movers